Liver TransplantationTransplantation, HomologousKidney TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationHeart TransplantationTransplantation, AutologousLung TransplantationStem Cell TransplantationTransplantation ConditioningOrgan TransplantationGraft SurvivalGraft RejectionPancreas TransplantationIslets of Langerhans TransplantationTissue DonorsTransplantationTransplantation ImmunologyCell TransplantationTransplantation ChimeraImmunosuppressive AgentsGraft vs Host DiseaseTransplantation, IsogeneicLiving DonorsTransplantation, HeterotopicTreatment OutcomeCord Blood Stem Cell TransplantationHeart-Lung TransplantationTissue and Organ ProcurementTransplantation TolerancePeripheral Blood Stem Cell TransplantationLiver FailureRetrospective StudiesImmunosuppressionHistocompatibility TestingFetal Tissue TransplantationTime FactorsSkin TransplantationPostoperative ComplicationsWaiting ListsTransplantation, HeterologousRecurrenceMesenchymal Stem Cell TransplantationCorneal TransplantationHistocompatibilityHematologic NeoplasmsTacrolimusTissue TransplantationWhole-Body IrradiationCyclosporineFollow-Up StudiesCadaverSurvival AnalysisSurvival RateBrain Tissue TransplantationFacial TransplantationDonor SelectionLiver DiseasesOrgan PreservationBusulfanTransplantsHLA AntigensKidney Failure, ChronicLeukemiaBronchiolitis ObliteransCombined Modality TherapyRisk FactorsAntilymphocyte SerumRemission InductionHand TransplantationAnemia, AplasticBlood Group IncompatibilityCytomegalovirus InfectionsMycophenolic AcidPostoperative PeriodMyeloablative AgonistsAcute DiseaseHematopoietic Stem CellsTissue and Organ HarvestingRats, Inbred LewMice, Inbred C57BLCyclophosphamidePrognosisEnd Stage Liver DiseaseLiverNeoplasm TransplantationPatient SelectionDisease-Free SurvivalBrain DeathProspective StudiesMelphalanLiver Failure, AcuteMultiple MyelomaT-LymphocytesPrimary Graft DysfunctionChimerismABO Blood-Group SystemCell DifferentiationLiver CirrhosisBone Marrow Cells